Nationales Centrum für Tumorerkrankungen

Heidelberg 69120

0 studies enrolling now · 3 studies all time

What they study most

PD-L1 Positive, Prostate Cancer, Triple Negative Breast Cancer, Uveal Melanoma

Studies at this site

• Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma — Completed
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer — Running, not enrolling
• DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) — Stopped early